Vor Bio to Participate in Upcoming Investor Conferences

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

conferences

Rhea-AI Summary

Vor Bio to participate in investor conferences

09/25/2023 - 08:00 AM

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Chardan’s 7^th Annual Genetic Medicines Conference
Fireside Chat: Monday, October 2, 2023 at 4:00 pm ET
Location: The Westin New York Grand Central, New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

JonesTrading 2023 Healthcare Summit
October 10-11, 2023
Location: Eden Rock Miami Beach, Miami, FL

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com